The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91430-1 · Cited by 1,183
Weinshilboum, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,031
Nelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., & Nebert, D. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200401000-00001 · Cited by 1,027
Stearns, V. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg108 · Cited by 850
A Single P450 Allele Associated with Insecticide Resistance in Drosophila
Daborn, P. J., Yen, J. L., Bogwitz, M. R., Le Goff, G., Feil, E., Jeffers, S., Tijet, N., Perry, T., Heckel, D., Batterham, P., et al. (2002) · Science · doi:10.1126/science.1074170 · Cited by 849
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
Zanger, U. M., Raimundo, S., & Eichelbaum, M. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0832-2 · Cited by 795
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
Bradford, L. D. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.2.229 · Cited by 773
Moving towards individualized medicine with pharmacogenomics
Evans, W. E., & Relling, M. V. (2004) · Nature · doi:10.1038/nature02626 · Cited by 768
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
Gonzalez, F. J., Skodat, R. C., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., & Meyer, U. A. (1988) · Nature · doi:10.1038/331442a0 · Cited by 715
Ingelman-Sundberg, M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.007 · Cited by 676
Self-citationJohansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
Self-citationPharmacogenetics and adverse drug reactions
Meyer, U. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03167-6 · Cited by 602
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
Ingelman-Sundberg, M., Oscarson, M., & McLellan, R. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01363-2 · Cited by 539
Self-citationGenotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
Heim, M., & Meyer, U. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)92086-w · Cited by 447
Johansson, I., Oscarson, M., Yue, Q. Y., Bertilsson, L., Sjöqvist, F., & Ingelman-Sundberg, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09721-4 · Cited by 430
Self-citationAklillu, E., Persson, I., Bertilsson, L., Johansson, I., Rodrigues, F., & Ingelman-Sundberg, M. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20152-5 · Cited by 392
Self-citationDiscombe, G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91898-4 · Cited by 376
Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
Ingelman-Sundberg, M. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0819-z · Cited by 353
Self-citationGoldstein, D. B., Tate, S. K., & Sisodiya, S. M. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1229 · Cited by 312
Hammer, W., & Sjöqvist, F. (1967) · Life Sciences · doi:10.1016/0024-3205(67)90218-4 · Cited by 262
Kaiser, R., Sezer, O., Papies, A., Bauer, S., Schelenz, C., Tremblay, P.-B., Possinger, K., Roots, I., & Brockmöller, J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.064 · Cited by 251
Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy
Ingelman‐Sundberg, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00879.x · Cited by 242
Self-citationChou, W. H., Yan, F.-X., de Leon, J., Barnhill, J., Rogers, T., Cronin, M., Pho, M., Xiao, V., Ryder, T. B., Liu, W. W., et al. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00019 · Cited by 226
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine
Bertilsson, L., Dahl, M.-L., Sjöqvist, F., Åberg-Wistedt, A., Humble, M., Johansson, I., Lundqvist, E., & Ingelman-Sundberg, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)92546-6 · Cited by 223
Self-citationFrequent occurrence of CYP2D6 gene duplication in Saudi Arabians
McLellan, R. A., Oscarson, M., Seidega??rd, J., Price Evans, D. A., & Ingelman-Sundberg, M. (1997) · Pharmacogenetics · doi:10.1097/00008571-199706000-00003 · Cited by 204
Self-citationBrockmöller, J., Kirchheiner, J., Schmider, J., Walter, S., Sachse, C., Müller‐Oerlinghausen, B., & Roots, I. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127494 · Cited by 204
Skoda, R. C., Gonzalez, F. J., Demierre, A., & Meyer, U. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5240 · Cited by 195
Wuttke, H., Rau, T., Heide, R., Bergmann, K., Böhm, M., Weil, J., Werner, D., & Eschenhagen, T. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127111 · Cited by 175
Dahl, M.-L. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241070-00001 · Cited by 163
�gren, H., Bertilsson, L., Kawanishi, C., & Lundgren, S. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0701-4 · Cited by 159
Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.
Yu, A., Idle, J. R., Byrd, L. G., Krausz, K. W., Kupfer, A., & Gonzalez, F. J. (2003) · PubMed · doi:10.1097/01.fpc.0000054066.98065.7b · Cited by 158
Amichot, M., Tarès, S., Brun‐Barale, A., Arthaud, L., Bride, J., & Bergé, J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04025.x · Cited by 141
A Combination of Mutations in the CYP2D6*17(CYP2D6Z) Allele Causes Alterations in Enzyme Function
Oscarson, M., Hidestrand, M., Johansson, I., & Ingelman‐Sundberg, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1034 · Cited by 141
Self-citationEvolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6
Heim, M. H., & Meyer, U. (1992) · Genomics · doi:10.1016/s0888-7543(05)80282-4 · Cited by 135
Danielson, P. B., MacIntyre, R., & Fogleman, J. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10797 · Cited by 120
Fonné‐Pfister, R., & Meyer, U. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90063-9 · Cited by 116
Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase.
Yu, A., Idle, J. R., Herraiz, T., Kupfer, A., & Gonzalez, F. J. (2003) · PubMed · doi:10.1097/01.fpc.0000054094.48725.b7 · Cited by 111
Yu, A., Kneller, B. M., Rettie, A. E., & Haining, R. L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039891 · Cited by 105
Aklillu, E., Herrlin, K., Gustafsson, L. L., Bertilsson, L., & Ingelman‐Sundberg, M. (2002) · Pharmacogenetics · doi:10.1097/00008571-200207000-00005 · Cited by 95
Self-citationThe African‐specific CYP2D6*17 allele encodes an enzyme with changed substrate specificity
Wennerholm, A., Dandara, C., Sayi, J., Svensson, J., Abdi, Y. A., Ingelman‐Sundberg, M., Bertilsson, L., Hasler, J. A., & Gustafsson, L. L. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.120239 · Cited by 94
Self-citationPai, H. V., Kommaddi, R. P., Chinta, S. J., Mori, T., Boyd, M. R., & Ravindranath, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402337200 · Cited by 82
Wennerholm, A., Johansson, I., Hidestrand, M., Bertilsson, L., Gustafsson, L. L., & Ingelman‐Sundberg, M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00005 · Cited by 78
Self-citationInfluence of the defective metabolism of sparteine on its pharmacokinetics
Eichelbaum, M. F., Spannbrucker, N., & Dengler, H. J. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562060 · Cited by 73
LIVING AND DYING IN THE NINETEENTH CENTURY.
Jg, G., & Ps, R. (1963) · PubMed · Cited by 69
Association between cytochrome P450 2D6 genotype and harm avoidance
Roberts, R. L., Luty, S. E., Mulder, R., Joyce, P. R., & Kennedy, M. A. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20163 · Cited by 60
Polymorphic hydroxylation of perhexiline in vitro
Sørensen, L. B., Sørensen, R., Miners, J. O., Somogyi, A. A., Grgurinovich, N., & Birkett, D. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01805.x · Cited by 37
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“The molecular studies that followed were reviewed previously (Meyer & Zanger, 1997; Zanger et al., 2004; Ingelman-Sundberg, 2005).”
BackgroundIngelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Self-citationUncovering the roles of rare variants in common disease through whole-genome sequencing
Cirulli, E. T., & Goldstein, D. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2779 · Cited by 1,136
Cytochrome P450 Enzymes and Drug Metabolism in Humans
Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., He, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312808 · Cited by 1,070
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Metadata
- Authors
- Ingelman-Sundberg, M.
- Venue
- The Pharmacogenomics Journal
- Published
- 2004-10-19
- Volume
- 5
- Issue
- 1
- Pages
- 6-13
- ISSN
- 1470-269X (ISSN-L)
- 1473-1150
- OpenAlex
- W2138332753
- Cited by
- 1,108
- References
- 48
- FWCI
- 29.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.